BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34274114)

  • 1. The CHA
    Marzouka GR; Rivner H; Mehta V; Lopez J; Vaz I; Tang F; Ishwaran H; Goldberger JJ
    Am J Cardiol; 2021 Sep; 155():72-77. PubMed ID: 34274114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic parameters versus CHA2DS2-VASc score in prediction of overall cardiac events, heart failure, and stroke in non-valvular atrial fibrillation.
    Yang LT; Tsai WC; Su HM
    Cardiol J; 2018; 25(1):60-71. PubMed ID: 28714523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant).
    Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J
    Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHA
    Graves KG; May HT; Jacobs V; Knowlton KU; Muhlestein JB; Lappe DL; Anderson JL; Horne BD; Bunch TJ
    Heart Rhythm; 2019 Jan; 16(1):3-9. PubMed ID: 30611392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting stroke and death in patients with heart failure using CHA
    Son MK; Lim NK; Park HY
    BMC Cardiovasc Disord; 2019 Aug; 19(1):193. PubMed ID: 31395009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHA
    Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA2DS2-VASc Score.
    Lin YS; Chen YL; Chen TH; Lin MS; Liu CH; Yang TY; Chung CM; Chen MC
    JAMA Netw Open; 2018 Aug; 1(4):e180941. PubMed ID: 30646091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
    Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Guo T; Xi Z; Qiu H; Wang Y; Zheng J; Dou K; Xu B; Qiao S; Yang W; Gao R
    Ann Med; 2021 Dec; 53(1):2215-2224. PubMed ID: 34791980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining Prediction of Atrial Fibrillation-Related Stroke Using the P
    Maheshwari A; Norby FL; Roetker NS; Soliman EZ; Koene RJ; Rooney MR; O'Neal WT; Shah AM; Claggett BL; Solomon SD; Alonso A; Gottesman RF; Heckbert SR; Chen LY
    Circulation; 2019 Jan; 139(2):180-191. PubMed ID: 30586710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHA2DS2-VASc score performance to predict stroke after acute decompensated heart failure with and without reduced ejection fraction.
    Berkovitch A; Mazin I; Younis A; Shlomo N; Nof E; Goldenberg I; Beinart R
    Europace; 2019 Nov; 21(11):1639-1645. PubMed ID: 31390461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
    Komatsu T; Sato Y; Ozawa M; Kunugita F; Yoshizawa R; Morino Y; Nakamura M
    Int Heart J; 2014; 55(2):119-25. PubMed ID: 24632957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHA
    Harb SC; Wang TKM; Nemer D; Wu Y; Cho L; Menon V; Wazni O; Cremer PC; Jaber W
    Open Heart; 2021 Nov; 8(2):. PubMed ID: 34815301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score.
    Kabra R; Girotra S; Vaughan Sarrazin M
    J Am Coll Cardiol; 2016 Aug; 68(5):461-470. PubMed ID: 27470453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHA
    Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
    Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHA
    Xing Y; Sun Y; Li H; Tang M; Huang W; Zhang K; Zhang D; Zhang D; Ma Q
    Clin Interv Aging; 2018; 13():497-504. PubMed ID: 29636604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke.
    Lau KK; Chan PH; Yiu KH; Chan YH; Liu S; Chan KH; Yeung CY; Li SW; Tse HF; Siu CW
    Cardiol J; 2014; 21(5):474-83. PubMed ID: 24846512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.